Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Allurion Technologies

Explore full profile

Allurion Breakthrough Weight Loss Technology

Natick, United StatesFounded 2009Biotech & Life Sciences
Valuation $12K Market cap · 2026
Revenue $15M Latest reported FY

About Allurion Technologies

Allurion Technologies Inc. is a pioneering company in the healthcare sector, specifically targeting obesity management. The company has developed the Allurion Balloon, the world's first weight loss balloon that does not typically require surgery, endoscopy (a procedure where a tube with a camera is inserted into the body), or anesthesia for placement or removal. This innovative product is designed to help patients lose weight safely and effectively.

The Allurion Program is comprehensive, combining the Allurion Balloon with a suite of digital tools and devices. These include the Allurion Virtual Care Suite, which features the Allurion Mobile App for consumers, Allurion Insights for clinicians, and the Allurion Connected Scale and Health Tracker devices. This integrated approach allows both patients and healthcare providers to customize, monitor, and manage weight loss therapy effectively.

Allurion primarily serves individuals struggling with obesity who are looking for non-surgical weight loss solutions. The company also collaborates with healthcare providers who offer the Allurion Program to their patients. The market for Allurion's products and services is global, although the Allurion Balloon is not currently approved in the United States.

The business model of Allurion is based on selling its weight loss balloon and the accompanying digital tools and devices. The company generates revenue through direct sales to healthcare providers and possibly through subscription services for its digital tools. By offering a full package of support, Allurion ensures a continuous revenue stream from both initial product sales and ongoing digital service subscriptions.

In summary, Allurion is revolutionizing the weight loss industry with its non-invasive, easy-to-use gastric balloon and comprehensive digital support system, aiming to make significant strides in the fight against obesity.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2009
Headquarters
Natick, United States
Listing
Public via SPAC 2023
Sector
Biotech & Life Sciences

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Romulus Capital
  • Novalis Lifesciences
  • Runway Growth Capital
  • 10X Capital

Series B and later6 investors entered at this stage

  • Massachusetts Life Sciences Center
  • IDO Investments
  • Chardan
  • Medtronic
  • RTW Investments
  • Compute Health Acquisition Corp
Team profiled 25 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
23 countries with
team presence
🇺🇸 United States28.2%
🇫🇷 France21.4%
🇪🇸 Spain10.7%
🇦🇪 United Arab Emirates5.8%
🇪🇬 Egypt4.8%
Top 5 of 23 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Allurion Technologies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Allurion Technologies on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.